GAYATRIBI
Gayatri BioOrganics financials
- Market cap
- ₹117 Cr
Quarterly results
Q1 FY27: net profit up 61.5% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| EBITDA | -0 | -0 | -0 | -0 | -0 −9% | -0 −62% | -0 −220% | 0 +106% |
| Net profit | -0 | -0 | -0 | -0 | -0 −17% | -0 −37% | -0 −147% | -0 +62% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −31.1% 1Y
1Y: ₹11.76 on 10 Sept 2025 → ₹8.1. High ₹20 (6 May 2026), low ₹6.55 (22 Jul 2026).
Financials, as filed
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Operating profit | ₹-1 Cr | ₹-0 Cr | ₹-1 Cr |
| Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Depreciation | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Net profit | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr |
| Cash from operations | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr |
| Free cash flow | ₹-1 Cr | ₹-1 Cr | ₹-1 Cr |
| ROCE | -44.5% | -40.7% | -92.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹79 Cr | ₹79 Cr | ₹79 Cr | ₹79 Cr | ₹79 Cr | ₹79 Cr |
| Reserves | ₹-112 Cr | ₹-112 Cr | ₹-113 Cr | ₹-114 Cr | ₹-115 Cr | ₹-116 Cr |
| Borrowings | ₹35 Cr | ₹35 Cr | ₹36 Cr | ₹36 Cr | ₹37 Cr | ₹38 Cr |
| Other liabilities | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| Total liabilities | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| Fixed assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| Total assets | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, DIIs trimmed −0.42 pp while the public added +0.42 pp. The shareholder count shrank 7% to 30,442.
- Promoters
- 21.6%
- FIIs
- 0.0%
- DIIs
- 0.2%
- Public
- 78.2%
Since Jun 2025
- DIIs −0.42 pp
- Public +0.42 pp
- Promoters 0.00 pp
How it drifted, 12 quarters
Over this window the public went from 58.7% to 78.2% — +19.5 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 40.6%, DIIs 0.7%, Public 58.7%.Dec '23: Promoters 40.6%, DIIs 0.7%, Public 58.7%.Mar '24: Promoters 40.6%, DIIs 0.7%, Public 58.7%.Jun '24: Promoters 40.6%, DIIs 0.7%, Public 58.7%.Sep '24: Promoters 40.6%, FIIs 0.0%, DIIs 0.7%, Public 58.7%.Dec '24: Promoters 43.8%, FIIs 0.0%, DIIs 0.7%, Public 55.6%.Mar '25: Promoters 21.6%, FIIs 0.0%, DIIs 0.7%, Public 77.8%.Jun '25: Promoters 21.6%, FIIs 0.0%, DIIs 0.7%, Public 77.8%.Sep '25: Promoters 21.6%, FIIs 0.0%, DIIs 0.7%, Public 77.8%.Dec '25: Promoters 21.6%, FIIs 0.0%, DIIs 0.7%, Public 77.8%.Mar '26: Promoters 21.6%, FIIs 0.0%, DIIs 0.7%, Public 77.8%.Jun '26: Promoters 21.6%, FIIs 0.0%, DIIs 0.2%, Public 78.2%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Indira Subbaramireddy Tikkavarapu newly disclosed 0.00% held
The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Gayatri BioOrganics Ltd above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Fursa Mauritius Spv 1 | 23.48% | unchanged |
| Sandeep Kumar Reddy Tikkavarapu | 21.59% | unchanged |
| Mahmed Raffe Pattan | 20.21% | unchanged |
| Kiran Kumar Gali | 13.09% | unchanged |
| G Nirmala Jyothi | 9.36% | unchanged |
| FII Mauritius-based Unclassified | 0.01% | unchanged |
| Indira Subbaramireddy Tikkavarapu | 0.00% | newly disclosed |
| Gayatri Fin Holdings Private Limited | 0.00% | unchanged |
| Tsr Holdings Private Limited | 0.00% | unchanged |
| Gayatri Capital Ltd | 0.00% | unchanged |
| Tikkavarapu Sarita Reddy | 0.00% | unchanged |
| Subbarami Reddy Tikkavarapu | 0.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Gayatri BioOrganics Ltd
Guides on how to read this kind of business and the numbers that matter.